← Eichor
Study identifier: NCT07663500 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Integrated Intrapartum Supportive Care and Pushing Strategies in Women Receiving Low-Dose Epidural Analgesia

Condition: Labor, Obstetric · Epidural Analgesia, Obstetric · Labor Duration  ·  Sponsor: National Taipei University of Nursing and Health Sciences

PhaseNA
Planned participants159
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This prospective, three-arm, non-randomized quasi-experimental study aims to evaluate integrated intrapartum supportive care combined with different pushing strategies among women at 37-42 weeks of gestation who receive low-dose epidural analgesia. Participants receive integrated intrapartum supportive care combined with spontaneous pushing, integrated intrapartum supportive care combined with immediate pushing, or routine intrapartum care combined with immediate pushing. The primary outcomes are the durations of the first and second stages of labor. Secondary outcomes include mode of birth, obstetric interventions, maternal outcomes, and neonatal outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Wan-Lin Pan, PhD  ·  +886-2-2822-7101 ext. 7101  ·  wanlimp@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Taiwan Adventist HospitalTaipei, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07663500